AllSight
Companies · RXRX · Biological Products, (No Diagnostic Substances)

RECURSION PHARMACEUTICALS, INC. (RXRX)

RECURSION PHARMACEUTICALS, INC. (RXRX) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

Aug 5, 2026
Revenue missed consensus as spending guidance fell; Genentech advanced a target.
Related companies in Biological Products, (No Diagnostic Substances)
BCRXKYMRRVMDEXELPCVXTWSTIMCRGLUEIOVATARSRGNXSRRK
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact